NCI-Designated Comprehensive Cancer Center
Moments in Time A History of Fox Chase Cancer Center
Your Health Care Team
Our unique staff of health-care professionals focus solely on oncology.
Read more »
Not many institutions receive the National Cancer Institute's highest designation.
Fox Chase Cancer Center is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, one of only 45 centers in the country to qualify for this highest level of designation.
As a result, Fox Chase physicians and researchers are frequently involved in setting new guidelines for breakthrough medicine and comprehensive care.
The National Cancer Institute (NCI), established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. Fox Chase Cancer Center has the highest level of designation given by the NCI.
What's the Difference Between an NCI Cancer Center and an NCI Comprehensive Cancer Center?
An NCI-designated cancer center means that a center has met NCI standards for cancer prevention, clinical services, or research. A Comprehensive Cancer Center meets NCI standards in all three categories.This NCI designation supports research, training, health information dissemination and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. Fox Chase's five CORE research programs range from understanding the fundamental mechanisms of biomolecular reactions in our Cancer Biology and Blood Cell Development and Function programs, therapy development in our Molecular Therapeutics program to disease management in our Cancer Prevention and Control program. These programs are made possible by our world-renowned researchers and the support of the NCI and donors. Learn more at cancer.gov
The National Comprehensive Cancer Network
Fox Chase Cancer Center is a member of the National Comprehensive Cancer Network® (NCCN), a not-for-profit alliance of 23 of the world's leading cancer centers dedicated to improving the quality and effectiveness of care provided to patients with cancer. More than 160,000 new patients receive cancer care at NCCN Member Institutions over the course of any year.
The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. As a member of the NCCN, Fox Chase offers its patients superior treatments, the latest technologies and broader access to clinical trials through our multidisciplinary team of physicians, health care professionals and researchers.